Similar companies
Income Statement (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Revenue | 58M | 9.4% |
| Gross Profit | 37M | 17.2% |
| Cost of Revenue | 21M | 1.9% |
| Operating expense | 59M | 1.8% |
| Net Income | -21M | 18.2% |
| EBITDA | -19M | 27.6% |
Balance Sheet (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 374M | 0.1% |
| Total Liabilities | 133M | 8.4% |
| Total Equity | 241M | 4.2% |
| Shares Outstanding | 52M | 0.5% |
Cash Flow (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | -19M | 19.5% |
| Cash from investing | -250,000 | 76.4% |
| Cash from financing | 1.7M | 67.6% |
EPS
Financial Highlights for PROCEPT BioRobotics in Q3 '24
PROCEPT BioRobotics reported a revenue of 58M, which is a 9.4% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 37M, marking a 17.2% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 21M, a -1.9% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 59M, showing a 1.8% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -21M, showing a 18.2% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -19M, showing a 27.6% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for PROCEPT BioRobotics with growth in revenue, gross profit, and net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
